Director, Medical Writing

lyellimmunopharma

United States

On-site

USD 180,000 - 280,000

Full time

14 days+

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Job summary

Lyell Immunopharma seeks a Director of Medical Writing to build and lead the medical writing function, initially as author and owner of regulatory documents. The role partners with Regulatory and Clinical Development to produce timely, regulator-ready text for protocols, ICFs, DSURs, and CSRs while scaling through BLA submissions and commercial launch.

Reporting to the VP of Regulatory Affairs, you will manage CROs and vendors, establish templates and SOPs, and drive efficiency with AI-enabled

Qualifications

  • Lead author for protocols and amendments, coordinating with Clinical Development, Biostatistics, Operations, and Safety.
  • Own the Investigator's Brochure lifecycle with updates and safety-driven revisions.
  • Author Clinical Study Reports to ICH E3 end-to-end, including data interpretation and QC.

Responsibilities

  • Author Module 2.5 (Clinical Overview) and Module 2.7 series covering efficacy, safety, pharmacology, and benefit-risk.
  • Develop the clinical submission content plan and ensure consistency across summaries, CSRs, and labeling.
  • Partner with Regulatory Affairs on eCTD granularity, cross-referencing conventions, and readiness for submission.
  • Oversee medical writing CROs, freelance writers, and service providers.

Skills

Regulatory writing
ICH E3 familiarity
Clinical study reports
Module 2 authoring
Vendor management
AI writing tools
Cross-functional collaboration
SOPs and templates

Job description

Using living cells to treat - and sometimes even cure - cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies. However, these profound results have not yet been achieved in patients with solid tumors, representing approximately 90% of all cancers. And for patients with hematologic malignancies, there is a need for next-generation cell therapies that can deliver increased response rates and longer duration of response. We are a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with solid tumors or hematologic malignancies. Lyell's product candidates are enhanced with novel technology designed to generate T cells that resist exhaustion and have qualities of durable stemness in order to drive durable tumor cytotoxicity and achieve consistent and long-lasting clinical response. We were founded by cell therapy pioneers whose decades of research elevated the broader understanding of T-cell biology and its interaction with cancer. In our quest to advance next-generation CAR T-cell therapies, we have built a fully integrated company capable of discovering new technologies, translating science into therapies, manufacturing cell therapy products, and clinically evaluating them in patients. Our culture is based on Science, Respect, Collaboration, and Courage and reflects who we are, the environment we create, and our mission's urgency.

We are seeking a Director of Medical Writing to build Lyell's medical writing capability; initially operating as author and independent owner of our clinical regulatory documents, with long term responsibility for building out the function as we advance our cell therapy portfolio through BLA submission and into commercial launch.

Reporting to the VP of Regulatory Affairs, this individual will partner with Regulatory and Clinical Development providing responsive, available, and action-focused support, able to turn a design discussion into draft text quickly. Recurring deliverables are protocols, protocol amendments, Investigator's Brochures, and clinical study reports, which move on clinical timelines and cannot slip. In parallel, you will author Module 2 clinical summary content as the submission takes shape.

Key Responsibilities
Clinical Document Ownership - Core of the Role

Lead author for protocols and amendments, working with Clinical Development, Biostatistics, Clinical Operations, and Safety to turn study design into clear, executable, regulator-ready text.

Own the Investigator's Brochure lifecycle - annual updates, safety-driven revisions, and manufacturing or product changes - keeping the benefit-risk narrative accurate as the data set matures.

Author Clinical Study Reports to ICH E3 end-to-end: TLF shell review, data interpretation, draft cycles, comment resolution, and QC.

Author supporting documents: ICF templates, DSURs, clinical sections of annual reports, and synopses.

Module 2 Authoring

Author Module 2.5 (Clinical Overview) and the Module 2.7 series: clinical efficacy, safety, clinical pharmacology, and benefit-risk.

Develop the clinical submission content plan: storyline across modules, data dependencies, and consistency across clinical summaries, protocols/CSRs, and labeling.

Partner with Regulatory Affairs on eCTD granularity, cross-referencing conventions, and submission-readiness review.

Vendor and Resource Management

Own selection, onboarding, and performance management of medical writing CROs, freelance writers, and functional service providers.

Build the operating model: scoping, SOWs and budgets, timeline negotiation, capacity forecasting, escalation paths, and the build-versus-buy calls behind them.

Enforce quality on outsourced work, ensuring that final product reflects Lyell and our best thinking.

Process and Infrastructure

Establish and maintain templates, style guide, authoring conventions, and medical writing SOPs and work instructions.

Implement or optimize document management, collaborative authoring, and reference management systems suited to a lean team that are scalable as we grow.

Lead comment resolution and review meetings, drive documents to closure across competing priorities, and support inspection readiness and audit response on document control.

AI-Enabled Authoring and Efficiency

One writer supporting continuous clinical deliverables and a marketing application cannot scale through effort alone. This role uses AI tooling as a force multiplier and manages our AI medical writing vendor relationship. Apply AI to multiple lay

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Director, Medical Writing
Director, Medical Writing

Lyell Immunopharma • United States

On-site
USD 220,000 - 240,000
Director, Medical Writing USA
Director, Medical Writing USA

Lyell • United States

On-site
USD 220,000 - 240,000
Director of Medical Writing — CAR-T Regulatory Leader
Director of Medical Writing — CAR-T Regulatory Leader

Lyell • United States

On-site
USD 220,000 - 240,000
Director of Medical Writing & Regulatory Content
Director of Medical Writing & Regulatory Content

lyellimmunopharma • United States

On-site
USD 180,000 - 280,000
Director, Medical Writing — Regulatory Strategy & Submissions
Director, Medical Writing — Regulatory Strategy & Submissions

Lyell Immunopharma • United States

On-site
USD 220,000 - 240,000
Medical Writing Director
Medical Writing Director

Sironax • Waltham (MA)

On-site
USD 180,000 - 240,000
Associate Director, Medical Writing - Clinical & Regulatory
Associate Director, Medical Writing - Clinical & Regulatory

Syneos Health, Inc. • Philadelphia

On-site
USD 140,000 - 210,000
Associate Director, Medical Writing - Clinical & Regulatory
Associate Director, Medical Writing - Clinical & Regulatory

Syneos Health, Inc. • Princeton (NJ)

On-site
USD 140,000 - 230,000
Associate Director, Medical Writing - Clinical & Regulatory
Associate Director, Medical Writing - Clinical & Regulatory

Taylor Strategy Partners • Atlanta (GA)

On-site
USD 180,000 - 230,000
Associate Director, Medical Writer
Associate Director, Medical Writer

Blueprint Medicines • United States

On-site
USD 90,000 - 150,000